<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02024035</url>
  </required_header>
  <id_info>
    <org_study_id>ART-ORL</org_study_id>
    <secondary_id>ET 2009-044</secondary_id>
    <nct_id>NCT02024035</nct_id>
  </id_info>
  <brief_title>Protocole Advanced RadioTherapy ORL</brief_title>
  <acronym>ART-ORL</acronym>
  <official_title>Health Economic Evaluation of Tomotherapy and Dynamic Arctherapy in ENT Epidermoid Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Leon Berard</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Biostatistics and Therapy Evaluation Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Leon Berard</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to do health economic evaluation of tomotherapy and dynamic
      arctherapy (2 techniques exist: RapidArc and Vmat).

      This study evaluate also local disease control after 18 months in patients with an ENT
      epidermoid carcinoma and treated by tomotherapy orarctherapy .

      The number of patients required in this study is: 300:

        -  Number of patients treated with tomotherapy: 120

        -  Number of patients treated with dynamic arctherapy RapidArc: 120

        -  Number of patients treated with dynamic arctherapy Vmat: 60

      This is a prospective; multicentric and non randomized study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The various of cost between tomotherapy and Intensity Modulation Radiation Therapy (IMRT)</measure>
    <time_frame>18 months</time_frame>
    <description>The purpose of this study is to realise a Health economic evaluation of the various cost between tomotherapy and Intensity Modulation Radiation Therapy (IMRT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The economic impact of the learning curve of the tomotherapy process, the operating procedures and the activity of the centres</measure>
    <time_frame>18 months</time_frame>
    <description>To estimate the economic impact of the learning curve of the tomotherapy process, the operating procedures and the activity of the centres</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the difference of cost for the preparation phase and the irradiation phase of the radiotherapy procedure</measure>
    <time_frame>18 months</time_frame>
    <description>One of the secondary objectives for the economic evaluation is to individualize the difference of cost for the preparation phase and the irradiation phase of the radiotherapy procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The salivary toxicity</measure>
    <time_frame>at 6; 12 and 18 months post treatment</time_frame>
    <description>The salivary function will be assessed at baeline; 6; 12 and 18 months post treatment.
This evaluation will be done with differents scale (RTOG, EVA); and with salivary scan.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the rate of disease local control</measure>
    <time_frame>Baseline, Month 6; Month 18</time_frame>
    <description>Assement of disease by clinical exam and/or imaging.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Head and Neck Squamous Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Tomotherapy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Arc'therapy Vmat</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Arctherapy Rapid'Arc</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <arm_group_label>Tomotherapy</arm_group_label>
    <arm_group_label>Arc'therapy Vmat</arm_group_label>
    <arm_group_label>Arctherapy Rapid'Arc</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with Cavum Epidermoïd or undifferentiated carcinoma; or oropharynx epidermoïd
        carcinoma; or oral cavity epidermoïd carcinoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PS &lt;= 2

          -  Age &gt;= 18 years

          -  Histologically proven carcinoma

          -  Cavum Epidermoïd or undifferentiated carcinoma; or oropharynx epidermoïd carcinoma; or
             oral cavity epidermoïd carcinoma

          -  Stade T1 to T4

          -  M0

          -  Patient with no surgery ( except laser partial surgery and ganglionic cleaning out)

          -  Bilateral ganlionic cervical area irradiation

          -  Covered by a medical insurance.

        Exclusion Criteria:

          -  Prior history of other malignancies in the last 5 years(except non evolutive ENT
             cancer or squamous cell carcinoma )

          -  Re-irradiation indication

          -  Unilateral cervical area irradiation

          -  Post-operative radiotherapy

          -  Patient treated by amifostine

          -  Impossible follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe GIRAUD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Europeen Georges Pompidou, Paris; FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Sainte Catherine</name>
      <address>
        <city>Avignon</city>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut BERGONIE</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>5900</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Privé de Radiothérapie de Metz</name>
      <address>
        <city>Metz</city>
        <zip>57072</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Alexis Vautrin</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Eurppéen Geoges POMPIDOU</name>
      <address>
        <city>Paris 15</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intitut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre René GAUDUCHEAU</name>
      <address>
        <city>St HERBLAIN</city>
        <zip>44800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Paul STRAUSS</name>
      <address>
        <city>Strasbourg</city>
        <zip>67085</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Oncorad Garonne</name>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2011</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2013</study_first_posted>
  <last_update_submitted>December 23, 2013</last_update_submitted>
  <last_update_submitted_qc>December 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tomotherapy</keyword>
  <keyword>Head and neck squamous celle carcinoma</keyword>
  <keyword>Health economic evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

